Mannose-Binding Lectin 2 (MBL2) is a key component of the innate immune system and a member of the collectin family of proteins. It functions as a soluble pattern recognition receptor that recognizes carbohydrate patterns on the surface of pathogens, including bacteria, fungi, and viruses. MBL2 plays a critical role in the lectin pathway of complement activation, which is one of the three major pathways of the innate immune system. Beyond its classical immunological functions, emerging research has implicated MBL2 in neurodegeneration through its involvement in neuroinflammation, protein aggregation, and [blood-brain barrier](/entities/blood-brain-barrier) integrity.
Mannose-Binding Lectin 2 (MBL2) is a key component of the innate immune system and a member of the collectin family of proteins. It functions as a soluble pattern recognition receptor that recognizes carbohydrate patterns on the surface of pathogens, including bacteria, fungi, and viruses. MBL2 plays a critical role in the lectin pathway of complement activation, which is one of the three major pathways of the innate immune system. Beyond its classical immunological functions, emerging research has implicated MBL2 in neurodegeneration through its involvement in neuroinflammation, protein aggregation, and [blood-brain barrier](/entities/blood-brain-barrier) integrity.
Structure and Function
Protein Structure
MBL2 is a multimeric protein composed of identical polypeptide chains that assemble into higher-order oligomers. The protein structure includes:
Collagen-like regions: Triple helical domains that mediate trimerization
C-type lectin domains: Carbohydrate recognition domains (CRDs) that bind to mannose, N-acetylglucosamine, and fucose residues on pathogen surfaces
Neck regions: Alpha-helical segments that facilitate oligomerization
N-terminal cysteine-rich regions: Involved in disulfide bond formation
The functional MBL2 protein circulates as large oligomers (typically trimers and hexamers) with molecular weights ranging from 200-600 kDa. This multimeric structure enables high-avidity binding to pathogen surfaces.
The Lectin Pathway
MBL2 initiates the lectin pathway of complement activation by:
Pattern recognition: MBL2 binds to pathogen-associated molecular patterns (PAMPs) on microbial surfaces
MBL-associated serine protease (MASP) recruitment: MBL2 complexes with MASP-1, MASP-2, and MASP-3
Complement activation: The MBL-MASP complex cleaves C4 and C2, generating C4b2a (C3 convertase)
downstream complement activation: This leads to opsonization, inflammation, and lysis of targets
Role in Neurodegeneration
Neuroinflammation
Neuroinflammation is a hallmark of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) (AD) and [Parkinson's disease](/diseases/parkinsons-disease). MBL2 contributes to neuroinflammation through several mechanisms:
Peripheral immune activation: Circulating MBL2 can activate the [complement system](/entities/complement-system), leading to systemic inflammation that propagates to the central nervous system
Blood-brain barrier (BBB) modulation: MBL2 and complement activation products can compromise BBB integrity, allowing peripheral immune cells to enter the brain
Microglial activation: Complement components generated by MBL2 activation can bind to microglia receptors, promoting pro-inflammatory cytokine release
Alzheimer's Disease
In Alzheimer's disease, MBL2 has been studied for its potential protective and pathogenic roles:
Amyloid-β clearance: Some studies suggest MBL2 may aid in clearing [amyloid-beta](/proteins/amyloid-beta) plaques through complement-mediated phagocytosis
Synaptic pruning: Excessive complement activation driven by MBL2 may contribute to synaptic loss in AD
Genetic associations: Polymorphisms in the MBL2 gene have been linked to altered AD risk in some populations
Parkinson's Disease
MBL2 involvement in Parkinson's disease relates to its role in:
Alpha-synuclein aggregation: MBL2 may interact with [alpha-synuclein](/proteins/alpha-synuclein) and influence aggregation kinetics
Microglial activation: The complement pathway contributes to neuroinflammation in PD
[Gut-brain axis](/entities/gut-brain-axis): MBL2 recognizes pathogens in the gut, potentially affecting the gut-brain axis in PD
Therapeutic Implications
MBL2 represents a potential therapeutic target for neurodegenerative diseases:
MBL inhibition: Inhibiting MBL2-mediated complement activation may reduce neuroinflammation
MBL replacement: In individuals with MBL deficiency, replacement therapy might support immune function
Modulation strategies: Small molecules that modulate MBL2 function could have neuroprotective effects
Clinical Significance
MBL2 Polymorphisms
Common polymorphisms in the MBL2 gene affect protein levels and function:
Promoter variants: The -550 G/C (rs11003124), -221 G/C (rs7096206), and +4 C/T (rs7095891) polymorphisms influence MBL2 expression
Coding variants: Codon 52 (Arg→Cys, rs5030737), codon 54 (Gly→Asp, rs1800450), and codon 57 (Gly→Glu, rs1800451) variants affect oligomerization and function
These polymorphisms determine MBL2 serum concentrations, ranging from deficient (<100 ng/mL) to high (>1000 ng/mL) levels.
MBL2 Deficiency
MBL2 deficiency affects approximately 5-10% of populations and increases susceptibility to infections. However, the relationship between MBL2 deficiency and neurodegeneration remains complex:
Some studies suggest MBL2 deficiency may paradoxically reduce neuroinflammation
Others indicate increased infection-related neuronal damage in deficient individuals
See Also
Innate Immune System
[Complement System in Neurodegeneration](/diseases/neurodegeneration)